Alteration of humoral, cellular and cytokine immune response to inactivated influenza vaccine in patients with Sickle Cell Disease.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 10 07 2019
accepted: 02 10 2019
entrez: 11 10 2019
pubmed: 11 10 2019
medline: 11 3 2020
Statut: epublish

Résumé

Patients suffering from Sickle Cell Disease (SCD) are at increased risk for complications due to influenza virus. Annual influenza vaccination is strongly recommended but few clinical studies have assessed its immunogenicity in individuals with SCD. The aim of this study was to explore the biological efficacy of annual influenza vaccination in SCD patients by characterizing both their humoral and cell-mediated immunity against influenza antigen. We also aimed to investigate these immunological responses among SCD individuals according to their treatment (hydroxyurea (HU), chronic blood transfusions (CT), both HU and CT or none of them). Seventy-two SCD patients (49 receiving HU, 9 on CT, 7 with both and 7 without treatment) and 30 healthy controls were included in the study. All subjects received the tetravalent influenza α-RIX-Tetra® vaccine from the 2016-2017 or 2017-2018 season. Protective anti-influenza HAI titers were obtained for the majority of SCD patients one month after vaccination but seroconversion rates in patient groups were strongly decreased compared to controls. Immune cell counts, particularly cellular memory including memory T and memory B cells, were greatly reduced in SCD individuals. Functional activation assays confirmed a poorer CD8+ T cell memory. We also document an imbalance of cytokines after influenza vaccination in SCD individuals with an INFγ/IL-10 ratio (Th1-type/Treg-type response) significantly lower in the SCD cohort. SCD patients undergoing CT showed altered immune regulation as compared to other treatment subgroups. Altogether, the cytokine imbalance, the high regulatory T cell levels and the low memory lymphocyte subset levels observed in the SCD cohort, namely for those on CT, suggest a poor ability of SCD patients to fight against influenza infection. Nevertheless, our serological data support current clinical practice for annual influenza vaccination, though immunogenicity to other vaccines involving immunological memory might be hampered in SCD patients and should be further investigated.

Identifiants

pubmed: 31600331
doi: 10.1371/journal.pone.0223991
pii: PONE-D-19-19282
pmc: PMC6786629
doi:

Substances chimiques

Influenza Vaccines 0
Interleukin-10 130068-27-8
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0223991

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

JAMA. 2014 Sep 10;312(10):1033-48
pubmed: 25203083
Ugeskr Laeger. 2003 Apr 14;165(16):1648-9
pubmed: 12756819
JAMA Netw Open. 2018 Oct 5;1(6):e183742
pubmed: 30646262
Front Immunol. 2018 Jan 08;8:1872
pubmed: 29358933
Clin Diagn Lab Immunol. 1996 May;3(3):301-4
pubmed: 8705673
Nat Med. 2010 May;16(5):558-64, 1p following 564
pubmed: 20436484
J Pediatr Hematol Oncol. 2005 Mar;27(3):158-61
pubmed: 15750449
Pediatr Blood Cancer. 2012 Dec 15;59(7):1280-3
pubmed: 22628221
Vaccine. 2010 Aug 31;28(38):6145-51
pubmed: 20646987
Pediatr Blood Cancer. 2015 Aug;62(8):1427-36
pubmed: 25810327
Br J Haematol. 2015 Sep;170(6):757-67
pubmed: 26018640
Transfus Clin Biol. 2015 Aug;22(3):178-81
pubmed: 26056038
J Clin Invest. 2006 Mar;116(3):808-16
pubmed: 16485041
Br J Haematol. 2015 May;169(4):574-83
pubmed: 25753210
Cochrane Database Syst Rev. 2013 Nov 14;(11):CD003146
pubmed: 24226646
Am J Hematol. 2016 Sep;91(9):938-46
pubmed: 27237467
Vaccines (Basel). 2016 Oct 13;4(4):
pubmed: 27754364
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):457-461
pubmed: 27913516
Clin Immunol. 2011 Mar;138(3):266-73
pubmed: 21215701
Blood. 2010 Mar 18;115(11):2329-30
pubmed: 20299522
Nat Med. 2013 Oct;19(10):1305-12
pubmed: 24056771
Br J Haematol. 2017 Jan;176(2):192-209
pubmed: 27858994
J Clin Immunol. 2003 Sep;23(5):385-400
pubmed: 14601647
Scand J Immunol. 2012 Apr;75(4):436-44
pubmed: 22420532
Chest. 2013 Feb 1;143(2):502-510
pubmed: 23381315
J Pediatr. 2012 Jan;160(1):74-81
pubmed: 21840537
Exp Hematol. 2016 Jul;44(7):583-9
pubmed: 27026283
Blood. 2010 Nov 4;116(18):3431-4
pubmed: 20656929
Pediatrics. 2010 Feb;125(2):234-43
pubmed: 20100764
Cytokine. 2014 Feb;65(2):217-21
pubmed: 24290434
Transfusion. 2018 Mar;58(3):804-815
pubmed: 29383722
Clin Infect Dis. 2010 Nov 1;51(9):1028-32
pubmed: 20887209
Pediatrics. 2013 Oct;132(4):e1089-104
pubmed: 23999962
Eur J Immunol. 2014 Jan;44(1):103-14
pubmed: 24114149
Cytometry. 1996 Dec 15;26(4):305-10
pubmed: 8979031

Auteurs

Carole Nagant (C)

Immunology Department, LHUB-ULB, Université libre de Bruxelles, Brussels, Belgium.

Cyril Barbezange (C)

National Influenza Centre, Sciensano, Brussels, Belgium.

Laurence Dedeken (L)

Department of Hematology Oncology, Hôpital Universitaire des Enfants Reine Fabiola, Université libre de Bruxelles, Brussels, Belgium.

Tatiana Besse-Hammer (T)

Department of Hematology Oncology, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.

Isabelle Thomas (I)

National Influenza Centre, Sciensano, Brussels, Belgium.

Bhavna Mahadeb (B)

Microbiology Department, LHUB-ULB, Université libre de Bruxelles, Brussels, Belgium.

André Efira (A)

Department of Hematology Oncology, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.

Alice Ferster (A)

Department of Hematology Oncology, Hôpital Universitaire des Enfants Reine Fabiola, Université libre de Bruxelles, Brussels, Belgium.

Francis Corazza (F)

Immunology Department, LHUB-ULB, Université libre de Bruxelles, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH